Log in to save to my catalogue

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vacc...

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vacc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8664658

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines

About this item

Full title

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2022-01, Vol.40 (3), p.414-417

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights•Our 1:2 cohort study included more than 1,4 million vaccinated people aged 75 years and older. •We observed an estimated 86% risk reduction of hospitalization for COVID-19. •Evidence of major impact of mRNA vaccination on reducing risk of COVID-19 among elderly people.

Alternative Titles

Full title

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8664658

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8664658

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518,0264-410X

DOI

10.1016/j.vaccine.2021.12.009

How to access this item